• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体溶解免疫聚集体的条件。经典途径的作用。

Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

作者信息

Takahashi M, Takahashi S, Brade V, Nussenzweig V

出版信息

J Clin Invest. 1978 Aug;62(2):349-58. doi: 10.1172/JCI109135.

DOI:10.1172/JCI109135
PMID:670397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC371772/
Abstract

In this paper we examine the role of the classical pathway in the complement-mediated solubilization of immune precipitates (CRA). Serum reagents were depleted of the alternative pathway components properdin and factor D. Both depleted reagents lack CRA although they have almost intact hemolytic activity. Also, immune complexes were not solubilized when incubated with high concentrations of the classical pathway components (C1, C4, C2, and C3. We conclude that CRA is not mediated by the classical pathway alone. Activation of the classical pathway by the immune aggregates greatly enhances CRA. The effect of the classical pathway is to deposit C3b on the antigen-antibody lattice and promote the assembly of a lattice-associated, properdin-dependent C3-convertase. Although C3, C4, and properdin were detected on complexes solubilized by serum in the presence of Ca++ and Mg++, only C3 and properdin were found on the complexes when Ca++ had been chelated by ethylene glycol-bis-(beta-aminoethyl ether), N,N'-tetraacetic acid. In both situations the aggregates were capable of converting C5 in the fluid phase. However, no C5 was found on the solubilized complexes. These findings suggest that in contrast to nascent C3b and C4b, nascent C5-9 lacks binding affinity for immune aggregates.

摘要

在本文中,我们研究了经典途径在补体介导的免疫沉淀物溶解(CRA)中的作用。血清试剂去除了替代途径成分备解素和D因子。两种去除后的试剂都缺乏CRA,尽管它们几乎具有完整的溶血活性。此外,当与高浓度的经典途径成分(C1、C4、C2和C3)一起孵育时,免疫复合物并未溶解。我们得出结论,CRA并非仅由经典途径介导。免疫聚集体对经典途径的激活极大地增强了CRA。经典途径的作用是在抗原-抗体晶格上沉积C3b,并促进与晶格相关的、备解素依赖性C3转化酶的组装。尽管在存在Ca++和Mg++的情况下,血清溶解的复合物上检测到了C3、C4和备解素,但当Ca++被乙二醇双(β-氨基乙醚)N,N'-四乙酸螯合时,复合物上仅发现了C3和备解素。在这两种情况下,聚集体都能够在液相中转化C5。然而,在溶解的复合物上未发现C5。这些发现表明,与新生的C3b和C4b相比,新生的C5-9对免疫聚集体缺乏结合亲和力。

相似文献

1
Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.补体溶解免疫聚集体的条件。经典途径的作用。
J Clin Invest. 1978 Aug;62(2):349-58. doi: 10.1172/JCI109135.
2
Solubilization of immune precipitates by complement in the absence of properdin or factor D.在缺乏备解素或D因子的情况下,补体对免疫沉淀物的溶解作用。
FEBS Lett. 1988 Jul 4;234(1):131-4. doi: 10.1016/0014-5793(88)81318-8.
3
Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.补体溶解免疫聚集体的条件:免疫复合物上B因子依赖性C3转化酶的组装。
J Exp Med. 1977 Jan 1;145(1):86-100. doi: 10.1084/jem.145.1.86.
4
Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.固相免疫复合物的补体结合。系统性红斑狼疮血清中能力降低。
J Clin Lab Immunol. 1988 Jun;26(2):73-9.
5
Solubilization of immune precipitates by six isolated alternative pathway proteins.六种分离出的替代途径蛋白对免疫沉淀物的溶解作用。
J Exp Med. 1981 Dec 1;154(6):1743-51. doi: 10.1084/jem.154.6.1743.
6
Studies on the mechanism of solubilization of immune precipitates by serum.血清溶解免疫沉淀物的机制研究。
J Exp Med. 1976 Mar 1;143(3):615-30. doi: 10.1084/jem.143.3.615.
7
Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.血浆蛋白C4结合蛋白和C3b灭活剂对经典途径C3转化酶的调节作用。
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600. doi: 10.1073/pnas.76.12.6596.
8
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.补体替代途径:不稳定的C3/C5转化酶招募前体备解素并增强该途径。
J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076.
9
Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.由肾炎因子稳定的经典和替代补体途径C3转化酶免受人类C3b受体介导的衰变作用。
Eur J Immunol. 1984 Dec;14(12):1111-4. doi: 10.1002/eji.1830141209.
10
The low C5 convertase activity of the C4A6 allotype of human complement component C4.人类补体成分C4的C4A6同种异型的低C5转化酶活性。
Biochem J. 1989 Aug 1;261(3):743-8. doi: 10.1042/bj2610743.

引用本文的文献

1
Follicular B2 Cell Activation and Class Switch Recombination Depend on Autocrine C3ar1/C5ar1 Signaling in B2 Cells.滤泡 B2 细胞的激活和类别转换重组依赖于 B2 细胞中的自分泌 C3ar1/C5ar1 信号。
J Immunol. 2019 Jul 15;203(2):379-388. doi: 10.4049/jimmunol.1900276. Epub 2019 Jun 19.
2
Deletion Variants of and Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy.和 缺失变异与系膜免疫沉积物相关,但与 IgA 肾病的进展无关。
J Am Soc Nephrol. 2018 Feb;29(2):661-669. doi: 10.1681/ASN.2017010019. Epub 2017 Nov 7.
3
Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.免疫复合物引发小鼠补体替代途径取决于IgG抗体中的N-聚糖。
Arthritis Rheum. 2008 Oct;58(10):3081-9. doi: 10.1002/art.23865.
4
Recombinant soluble Fc gamma RII inhibits immune complex precipitation.重组可溶性FcγRII抑制免疫复合物沉淀。
Clin Exp Immunol. 1995 Dec;102(3):620-5. doi: 10.1111/j.1365-2249.1995.tb03862.x.
5
A new role for complement in experimental membranous nephropathy in rats.补体在大鼠实验性膜性肾病中的新作用。
J Clin Invest. 1980 Dec;66(6):1339-50. doi: 10.1172/JCI109987.
6
Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.系统性红斑狼疮、肾炎或血管炎患者的补体介导溶解作用。
Clin Exp Immunol. 1981 Dec;46(3):557-64.
7
Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.补体从细胞受体释放系统性红斑狼疮免疫复合物的能力。
Clin Exp Immunol. 1981 May;44(2):416-25.
8
Enhancement of monocyte complement component synthesis by antigen--antibody complexes.抗原-抗体复合物对单核细胞补体成分合成的增强作用。
Immunology. 1981 Sep;44(1):193-200.
9
Kinetic studies of the association of complement components and IgG-coated latex particles incubated in normal or complement-activated human serum.在正常或补体激活的人血清中孵育的补体成分与IgG包被的乳胶颗粒结合的动力学研究。
Clin Exp Immunol. 1981 Apr;44(1):191-200.
10
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.补体介导的免疫沉淀抑制作用。I. 经典途径和替代途径的作用
Clin Exp Immunol. 1982 Mar;47(3):555-62.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The properdin system and immunity. X. Characterization of partially purified human properdin.备解素系统与免疫。X. 部分纯化的人备解素的特性
J Immunol. 1959 Oct;83:428-36.
3
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
4
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.C1酯酶对补体第四成分活性及理化性质的影响
J Exp Med. 1965 May 1;121(5):819-33. doi: 10.1084/jem.121.5.819.
5
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.高比放射性碘-131标记人生长激素的制备
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
6
The properdin system and immunity. IX. Studies on the purification of human properdin.备解素系统与免疫。IX. 关于人备解素纯化的研究。
J Immunol. 1959 Oct;83:418-27.
7
An alternative mechanism for the properdin system.备解素系统的另一种机制。
J Exp Med. 1958 Oct 1;108(4):515-35. doi: 10.1084/jem.108.4.515.
8
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.豚鼠血清中溶血补体九种成分的分离、纯化及测定方法
Immunochemistry. 1966 Mar;3(2):111-35. doi: 10.1016/0019-2791(66)90292-8.
9
Antibody-complement complexes.抗体-补体复合物
Science. 1965 Nov 12;150(3698):907-8. doi: 10.1126/science.150.3698.907.
10
Properdin factor D: characterization of its active site and isolation of the precursor form.备解素因子D:其活性位点的表征及前体形式的分离。
J Exp Med. 1974 Feb 1;139(2):355-66. doi: 10.1084/jem.139.2.355.